Roche, Ranbaxy Settlement Ends Valcyte Patent Battle
Ranbaxy Laboratories Ltd. has admitted that its proposed generic version of the antiviral drug Valcyte would infringe a patent asserted by Roche Palo Alto LLC and plans to launch its generic...To view the full article, register now.
Already a subscriber? Click here to view full article